TY  - JOUR
AU  - Hernandez-Garcia, Marta
AU  - Garcia-Castillo, Maria
AU  - Ruiz-Garbajosa, Patricia
AU  - Bou, German
AU  - Siller-Ruiz, Maria
AU  - Pitart, Cristina
AU  - Gracia-Ahufinger, Irene
AU  - Mulet, Xavier
AU  - Pascual, Alvaro
AU  - Tormo, Nuria
AU  - Canton, Rafael
PY  - 2022
DO  - 10.1128/aac.02161-21
UR  - http://hdl.handle.net/10668/20034
T2  - Antimicrobial agents and chemotherapy
AB  - Novel β-lactam-β-lactamase inhibitor combinations currently approved for clinical use are poorly active against metallo-β-lactamase (MBL)-producing strains. We evaluated the in vitro activity of cefepime-taniborbactam (FTB [formerly...
LA  - en
PB  - American Society for Microbiology
KW  - Carbapenemase-producing Enterobacterales
KW  - Carbapenemase-producing Pseudomonas aeruginosa
KW  - Cefepime-taniborbactam susceptibility
KW  - Anti-Bacterial Agents
KW  - Azabicyclo Compounds
KW  - Bacterial Proteins
KW  - Borinic Acids
KW  - Carboxylic Acids
KW  - Cefepime
KW  - Humans
KW  - Microbial Sensitivity Tests
KW  - Pseudomonas aeruginosa
KW  - Spain
KW  - beta-Lactamases
TI  - In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain.
TY  - research article
VL  - 66
ER  -